Skip to main content
. 2020 Nov 25;107(6):1178–1185. doi: 10.1016/j.ajhg.2020.11.007

Table 1.

Comparison of Clinical Features in SMG8- and SMG9-Mutated Individuals

Family 1 Family 2 Family 3 Family 4 SMG9-Mutated Individuals
Individual 19DG1424 MDLREQ20196451 19DG1391 19DG1396 19DG0152 19DG1342 19DG0377 10DF10800_a 10DF10800_b
Age 23 months fetus 7 y 19 y 18 y 28 y 10 y 8 y 3 y
Gender f ? m m m m f f m
CHD VSD, PFO, PLSVC, DCS ?LPAS VSD ASD, VSD 4/4
Facial dysmorphism + + + + + + + + + 4/4
GDD + NA + + + + + + + 4/4
Microcephaly + + borderline + + + + 3/3
Short stature + + borderline borderline + + 3/3
CNS anomalies ? wide CSP and ventricles AWM ? ? ? AWM, BA AWM 4/4
Eye findings ? strabismus strabismus cataract cataract cataract 3/4
GU ? dilated RCS, TUB, hypospadias hypospadias hypospadias 1/4

Age at last assessment is shown. Abbreviations are as follows: f, female; m, male; AWM, abnormal white matter; BA, brain atrophy; CHD, congenital heart disease; CNS, central nervous system; CSP, cavum septum pellucidum; DCS, dilated coronary sinus; GDD, global developmental delay; GU, genitourinary; LPAS, left pulmonary artery sling; PFO, patent foramen ovale; PLSVC, persistent left superior vena cava; RCS, renal collecting system; and VSD, ventricular septal defect.